Assessing the control of the disease on current treatments available in Romania for hereditary angioedema patients
Background: Acute treatment must be permanently accessible for every patient diagnosed with hereditary angioedema (HAE). In many cases this type of therapy does not provide/offer sufficient control of the disease, so long-term prophylaxis (LTP) is recommended. In the case of regular and prolonged/ex...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2024-06-01
|
Series: | Acta Marisiensis - Seria Medica |
Subjects: | |
Online Access: | https://doi.org/10.2478/amma-2024-0009 |